Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.
Clinical trial NCT02799082 · COMPLETED
Trial details
- NCT number
- NCT02799082
- Sponsor
- Biofrontera Bioscience GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2008-10-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.